UroGen Pharma Ltd.
Immunomodulating treatments of body cavities
Last updated:
Abstract:
Described herein are compositions and methods for treating cancer of a body cavity, specifically urinary tract cancer, by way of a combination of at least two immunomodulatory agents, wherein one or more of the therapeutic agents are embedded in, and slowly released from, a biocompatible hydrogel composition.
Status:
Grant
Type:
Utility
Filling date:
11 Mar 2019
Issue date:
1 Sep 2020